ACT Co., Ltd. (KOSDAQ:A131400) announced private placement of 6th non-guaranteed private equity convertible bonds for gross proceeds of KRW 15,000,000,000 to Nexton Bioscience Co., Ltd. on May 6, 2021. The bonds will have coupon rate of 2% and interest to maturity of 4%. The bonds will be issued at par and matures on May 7, 2024. The bonds are convertible into 2,658,631 shares at a fixed conversion price of KRW 5,642 per share from May 07, 2022 to April 07, 2024. The transaction is expected to close on May 7, 2021. The transaction was approved by the board of directors of the company.